Early toxicity of hypofractionated radiotherapy for prostate cancer

Autoři	KRUPA Pavel TICHA Hana KAZDA Tomáš DYMÁČKOVÁ Radana ZITTEBARTOVÁ Jana ODLOZILIKOVA Anna KOMINEK Libor BOBEK Lukas KUDLACEK Ales ŠLAMPA Pavel
Rok publikování	2016
Druh	Článek v odborném periodiku
Časopis / Zdroj	Biomedical Papers of the Faculty of Medicine of Palacký University, Olomouc, Czech Republic
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Doi	http://dx.doi.org/10.5507/bp.2016.008
Obor	Onkologie a hematologie
Klíčová slova	hypofractionationation; VMAT; volumetric arc therapy; RapidArc; Tumor control probability; Normal tissue complication probability; alternated time schedule
Popis	Hypofractionated accelerated radiotherapy (HART) is now a feasible option for prostate cancer treatment apropos toxicity, biochemical control and shortening of treatment. The aim of this study was to investigate hypofractionated schedules in the treatment of patients with localized prostate cancer.